$FOXO Balance Sheet | Understand Stock

$FOXO

$0.11 +$0.01 (6.7%) Close

$FOXO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Oct 9, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets
Prepaid consulting fees
Cash and cash equivalents
Accounts receivable, net
Inventory and supplies
Supplies
Prepaid expenses
Other current assets
Total current assets
Investments and cash held in Trust Account

Intangible assets
Reinsurance recoverables
Forward purchase collateral
Cloud computing arrangements
Property and equipment, net
Intangible assets, net
Investments
Cloud computing arrangements, net
Goodwill
Right-of-use assets
Other assets
Total assets

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable
The FOXO Note
Shares payable
Parallel run advance
PIK Notes
Related Party
Total pIK Notes
Related party payable
Related parties payables and promissory notes
Related parties’ payables and promissory notes
Accrued expenses
Related Party
Total accrued expenses
Accrued and other liabilities
Forward purchase put derivative
Forward purchase collateral derivative
Related party convertible debentures
Convertible debentures
Accrued settlement
Notes payable
Nonrelated Party
Related Party
Total notes payable
Senior PIK Notes
Related parties’ notes and loans payable
Other loans
Related parties’ payables and accrued expenses
Right-of-use lease obligations

Accrued and other liabilities
Total current liabilities
Deferred underwriting commission
Warrant liability
Warrant liability
Long term debt
Warrant liabilities
Senior PIK Notes
Policy reserves
Warrant liabilities
Related party payable
Third-party notes payable, net of current portion
Related Party
Total third-party notes payable, net of current portion

Contingent purchase price consideration
Right-of-use lease obligations, net of current portion
Other liabilities
Medicare cost report settlement payables
Total liabilities
Common stock subject to possible redemption; $0.0001 par value; 11,047,578 and 20,125,000 shares (at redemption value of approximately $10.04 and $10.00 per share) as of June 30, 2022 and December 31, 2021
Stockholders’ equity (deficit)
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, none issued or outstanding as of March 31, 2023 and December 31, 2022
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, 29,558,830 and 29,669,830 issued, and 27,418,069 and 27,529,069 outstanding as of March 31, 2023 and December 31, 2022, respectively
Preferred stock stated value
Series A Preferred Stock
Series D Preferred Stock
Series E Preferred Stock
Class A common stock, $0.0001 par value, 25,000,000,000 shares authorized, 1,420,652 and 831,887 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Class B common stock, $0.0001 par value, 7,000,000 shares authorized, 5,031,250 shares issued and outstanding as of June 30, 2022 and December 31, 2021
Additional paid-in-capital
Accumulated deficit

Total stockholders’ deficit
Total FOXO’s stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments